AbbVie
ABBV
ABBV
1,456 hedge funds and large institutions have $64.1B invested in AbbVie in 2014 Q2 according to their latest regulatory filings, with 98 funds opening new positions, 550 increasing their positions, 593 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 1,421 → 1,456 (+35)
2.12% more ownership
Funds ownership: 68.94% → 71.06% (+2.1%)
7% less repeat investments, than reductions
Existing positions increased: 550 | Existing positions reduced: 593
Holders
1,456
Holding in Top 10
69
Calls
$306M
Puts
$191M
Top Buyers
| 1 | +$659M | |
| 2 | +$354M | |
| 3 | +$183M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$163M |
| 5 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$152M |
Top Sellers
| 1 | -$684M | |
| 2 | -$142M | |
| 3 | -$137M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$122M |
| 5 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$115M |